HY-139423-10mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-100mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-25mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-5mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-139423-50mg
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5]
|
|
COVID-19-immunoregulation
|
|
HY-N0928-25mg
|
MedChemexpress LLC
|
Mimosine [CAS 500-44-7]
|
|
COVID-19-immunoregulation
|
|
HY-N0928-50mg
|
MedChemexpress LLC
|
Mimosine [CAS 500-44-7]
|
|
COVID-19-immunoregulation
|
|
HY-100256-1mL
|
MedChemexpress LLC
|
Trifarotene [CAS 895542-09-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10256-1mL
|
MedChemexpress LLC
|
Adezmapimod [CAS 152121-47-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-10256A-1mL
|
MedChemexpress LLC
|
Adezmapimod (hydrochloride) [CAS 869185-85-3] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-139423-1mL
|
MedChemexpress LLC
|
JAK1-IN-8 [CAS 1973485-18-5] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-W016867-1mL
|
MedChemexpress LLC
|
4-Chlorosalicylic acid [CAS 5106-98-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|